Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies

There is increasing recognition that pathogenic germ line variants drive the development of hematopoietic cancers in many individuals. Currently, patients with hereditary hematologic malignancies (HHMs) receive similar standard therapies and hematopoietic stem cell transplant (HSCT) approaches as th...

Descripción completa

Detalles Bibliográficos
Autores principales: Saygin, Caner, Roloff, Gregory, Hahn, Christopher N., Chhetri, Rakchha, Gill, Saar, Elmariah, Hany, Talati, Chetasi, Nunley, Emma, Gao, Guimin, Kim, Aelin, Bishop, Michael, Kosuri, Satyajit, Das, Soma, Singhal, Deepak, Venugopal, Parvathy, Homan, Claire C., Brown, Anna, Scott, Hamish S., Hiwase, Devendra, Godley, Lucy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Stimulus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979761/
https://www.ncbi.nlm.nih.gov/pubmed/36001442
http://dx.doi.org/10.1182/bloodadvances.2022008172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979761/
https://www.ncbi.nlm.nih.gov/pubmed/36001442
http://dx.doi.org/10.1182/bloodadvances.2022008172

Ejemplares similares